Cytocare Inc.: The firm posted a healthy...
- Share via
Cytocare Inc.: The firm posted a healthy second-quarter profit Thursday, giving its stock price a 30% boost.
The Aliso Viejo-based company, which makes products to treat urological diseases, reported earnings of $651,949, or 12 cents a share. That contrasted with a loss of $19,870 for the same period a year earlier. Revenue was up 3% to $3.8 million from $3.7 million.
In Thursday’s Nasdaq trading, Cytocare’s stock closed at $4.37 a share, up $1.
Year-to-date profit totaled $1.6 million, or 30 cents a share, compared to earnings of $397,001, or 7 cents a share, for the same period a year earlier. Six-month revenue was $8.3 million, up from $7.3 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
